About Us

about-image

Revolutionising Diagnosis in Eye Care Through Innovative Solutions

Narayana Nethralaya, one of the most trusted eye hospitals in India, has developed multiple research wings, including Narayana Netralaya Foundation. Narayana Netralaya Foundation has recently spun off a startup named Novomol-Dx with the aim of bringing cutting edge molecular research to the clinics worldwide.

Novomol-Dx stands for Novel Molecular Diagnostics. It was initiated with a vision to revolutionise eye care by leveraging cutting-edge technology for diagnosing and preventing eye diseases. Novomol-Dx is dedicated to advancing the standards of eye care and preserving vision for generations to come.

Novomol-Dx was established to bring validated clinical solutions to the market, aligning with the ‘Make in India’ initiative. The research wing, led by Dr. Arkasubhra Ghosh, collaborated with clinicians and engineers to address challenges in ocular health diagnosis.

Vision

We are dedicated to advancing the standards of eye care by leveraging cutting-edge technologies for diagnosing and preventing eye diseases.

Mission

To consistently introduce validated clinical solutions developed by our researchers and scientists in the sphere of eye care, thus empowering clinicians across the world in confidently and accurately managing the ocular health of their patients.

Our Founders

Dr-KBS

Dr. K Bhujang Shetty (Late)

Founder

Dr-Rohit-Shetty

Dr. Rohit Shetty

Chairman

Dr-Naren-Shetty

Dr. Naren Shetty

Vice Chairman

Our Partner

bio-techne-logo

Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated over $1.1 billion in net sales in fiscal 2023 and has approximately 3,100 employees worldwide.

Copyrights © 2025 NovoMol-Dx | All Rights Reserved | Terms and Conditions | Privacy Policy